{"id":"https://openalex.org/W2005877462","doi":"https://doi.org/10.1002/jps.2600570807","title":"Pharmacokinetics of Acetylsalicylic Acid and Salicylic Acid After Intravenous Administration in Man","display_name":"Pharmacokinetics of Acetylsalicylic Acid and Salicylic Acid After Intravenous Administration in Man","alternate_titles":[],"publication_year":1968,"publication_date":"1968-08-01","ids":{"openalex":"https://openalex.org/W2005877462","doi":"https://doi.org/10.1002/jps.2600570807","mag":"2005877462"},"language":"en","primary_location":{"id":"doi:10.1002/jps.2600570807","doi":"https://doi.org/10.1002/jps.2600570807","is_oa":false,"landing_page_url":"https://doi.org/10.1002/jps.2600570807","pdf_url":null,"source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Sciences","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005877462"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110588033","display_name":"Malcolm Rowland","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110664","display_name":"University of California San Francisco Medical Center","ror":"https://ror.org/01t8svj65","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210110664"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Malcolm Rowland","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, School of Pharmacy, University of California, San Francisco Medical Center, San Franoisco, CA 94122"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, School of Pharmacy, University of California, San Francisco Medical Center, San Franoisco, CA 94122","institution_ids":["https://openalex.org/I4210110664"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090403590","display_name":"Sidney Riegelman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110664","display_name":"University of California San Francisco Medical Center","ror":"https://ror.org/01t8svj65","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210110664"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sidney Riegelman","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, School of Pharmacy, University of California, San Francisco Medical Center, San Franoisco, CA 94122"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, School of Pharmacy, University of California, San Francisco Medical Center, San Franoisco, CA 94122","institution_ids":["https://openalex.org/I4210110664"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210110664"],"apc_list":{"value":3620,"currency":"USD","value_usd":3620},"apc_paid":null,"fwci":5.4472,"has_fulltext":false,"cited_by_count":192,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.961837,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"57","issue":"8","first_page":"1313","last_page":"1319"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.7846999764442444,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.7846999764442444,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.06350000202655792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.03790000081062317,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aspirin","display_name":"aspirin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/salicylic-acid","display_name":"salicylic acid","score":0.9929999709129333},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8989999890327454},{"id":"https://openalex.org/keywords/intravenous-administration","display_name":"intravenous administration","score":0.9980000257492065},{"id":"https://openalex.org/keywords/plasma-concentration-time-curve","display_name":"plasma concentration-time curve","score":0.7929999828338623},{"id":"https://openalex.org/keywords/biexponential-model","display_name":"biexponential model","score":0.6899999976158142},{"id":"https://openalex.org/keywords/half-life","display_name":"half-life","score":0.7459999918937683},{"id":"https://openalex.org/keywords/dose-proportionality","display_name":"dose proportionality","score":0.8320000171661377},{"id":"https://openalex.org/keywords/area-under-the-curve","display_name":"area under the curve","score":0.8140000104904175},{"id":"https://openalex.org/keywords/two-compartment-model","display_name":"two-compartment model","score":0.7910000085830688},{"id":"https://openalex.org/keywords/volume-of-distribution","display_name":"volume of distribution","score":0.7459999918937683}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8856338858604431},{"id":"https://openalex.org/C2778221352","wikidata":"https://www.wikidata.org/wiki/Q193572","display_name":"Salicylic acid","level":2,"score":0.8760699033737183},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.6890771985054016},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6083791255950928},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5965848565101624},{"id":"https://openalex.org/C139254425","wikidata":"https://www.wikidata.org/wiki/Q1332167","display_name":"Volume of distribution","level":3,"score":0.5100331902503967},{"id":"https://openalex.org/C192670549","wikidata":"https://www.wikidata.org/wiki/Q5361061","display_name":"Elimination rate constant","level":4,"score":0.47706663608551025},{"id":"https://openalex.org/C3941253","wikidata":"https://www.wikidata.org/wiki/Q47270","display_name":"Half-life","level":3,"score":0.46547362208366394},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.44264426827430725},{"id":"https://openalex.org/C3020079912","wikidata":"https://www.wikidata.org/wiki/Q3918988","display_name":"Plasma concentration","level":2,"score":0.43524643778800964},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2732008099555969},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.11127185821533203}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1002/jps.2600570807","doi":"https://doi.org/10.1002/jps.2600570807","is_oa":false,"landing_page_url":"https://doi.org/10.1002/jps.2600570807","pdf_url":null,"source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Sciences","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W1924842409","https://openalex.org/W1968170345","https://openalex.org/W1968876263","https://openalex.org/W1976692155","https://openalex.org/W1979748011","https://openalex.org/W1992688351","https://openalex.org/W2012973022","https://openalex.org/W2040542702","https://openalex.org/W2065204483","https://openalex.org/W2116346771","https://openalex.org/W2121893251","https://openalex.org/W2143711007","https://openalex.org/W2324367565","https://openalex.org/W2988461973"],"related_works":["https://openalex.org/W2055148507","https://openalex.org/W198723458","https://openalex.org/W1791573232","https://openalex.org/W2065204483","https://openalex.org/W271938698","https://openalex.org/W2334931860","https://openalex.org/W2404222116","https://openalex.org/W151559400","https://openalex.org/W1998652812","https://openalex.org/W2335700691"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2005877462","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
